Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational drug, riliprubart, for the ...

Matthew Dean, Sales Engineer and Head of the Medical Business Unit at maxon, explores how Newrotex and maxon are developing an innovative approach to overcome the common challenges of traditional ...

Patients with occipital headache experienced relief with 60 days of peripheral nerve stimulation, according to data presented at the American Headache Society 67th Annual Scientific Meeting.“Whenever ...